Nasdaq Composite ($NASX)

Although Regeneron Pharmaceuticals has lagged the Nasdaq over the past year, analysts remain highly bullish about its prospects.

Warren Buffett's famous Berkshire shareholder meeting quote from 1979 warns about being complacent in one's investment practice. Here's what lessons investors should take away for today's market.

Altria Group has notably outperformed the Nasdaq recently, and analysts remain moderately optimistic about the stock’s prospects.

Though Bristol-Myers Squibb has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

This blue-chip stock is down 27% YTD but is bouncing back following Anthropic's announcement regarding AI.

AppLovin has outperformed the Nasdaq over the past year, and analysts are highly optimistic about the stock’s prospects.

Mondelez has trailed the broader Nasdaq Composite over the past year, but analysts are fairly bullish about its future prospects.

Uber Technologies has underperformed relative to the Nasdaq over the past year, yet analysts are bullish about the stock’s prospects.

Pinterest is growing, but rich multiples and ad headwinds mean Cathie Wood’s trim isn’t a panic signal, just a reminder of execution risk.

The iShares Asia 50 ETF (AIA) is up a staggering 30% over the past few months. Here's where it might go from here and what investors should know.